DH: Rasio utang jangka dawa marang ekuitas Definitive Corp

Logo korporat perusahaan Definitive Corp (DH)

The growth of Definitive Healthcare (DH) is being constrained by aggressive cuts in analytics spending across Western countries and data localization requirements. Business efficiency relies on ARR growth and an operating margin, which stands at 1.02. This chart illustrating the price evolution of the quotes confirms the stability of the company, whose operations are entirely focused on the US domestic market, thereby eliminating any external political threats.

Definitive Corp (DH): Utang jangka dawa marang modal saka 04.07.2022 nganti 28.10.2026
Barang utama Definitive Healthcare Inc.

To minimize fundamental risks, investors select assets with low dependence on external borrowing by evaluating the ratio of liabilities with maturities exceeding one year to equity. This coefficient determines the share of long-term leverage within the financing structure, which is critical for Definitive Healthcare (DH) amid margin stagnation while scaling its SaaS model. By analyzing the long-term debt-to-equity trend, one can assess the business's resilience to crises.

Pesaing langsung

Koefisien utang jangka dawa marang modal VEEV|Utang jangka dawa marang ekuitas DOCS (Doximity Corp)|Rasio utang jangka dawa marang ekuitas HealthEquity Building (HQY)|WAY: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal corvel.com CRVL|Privia Health (PRVA) - Utang jangka dawa marang modal|HURN - Rasio utang jangka dawa marang modal|Utang jangka dawa marang modal Certara Corp|Omnicell Health (OMCL) - Rasio utang jangka dawa marang modal|Utang jangka dawa marang modal GDRX (GoodRx Holdings, Inc.)|Kewajiban jangka dawa marang modal schrodinger.com|PHR - Utang jangka dawa marang modal|Kewajiban jangka dawa marang ekuitas Omada Health, Inc. (OMDA)|Utang jangka dawa marang modal EVH|HealthStream Learning - Rasio tanggungan utang jangka dawa marang modal|Consensus Cloud Solutions (CCSI) - Utang jangka dawa marang ekuitas|AGL - Rasio utang jangka dawa marang modal|Absci Corporation - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal So-Young International Inc|National Research (NRC) - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka dawa marang modal USA Mobility|OPRX (OptimizeRx Corporation) - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal trubridge.com TBRG|Rasio utang jangka dawa marang ekuitas Simulations Plus SLP|Utang jangka dawa marang ekuitas Sophia Genetics SOPH|HCAT (Health Catalyst, Inc) - Utang jangka dawa marang modal|CareCloud, Inc. (CCLD) - Kewajiban jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Research Solutions RSSS|DLH Holdings (DLHC) - Koefisien utang jangka dawa marang modal|ONMD - Utang jangka dawa marang modal|Koefisien utang jangka dawa marang modal Scienture Holdings|Healthcare Triangle Corp - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal ispecimen.com (ISPC)|Utang jangka dawa marang modal BFRG (Bullfrog AI)|scworx.com - Utang jangka dawa marang modal|MSPR - Utang jangka dawa marang ekuitas|iCoreConnect Inc. (ICCT) - Utang jangka dawa marang ekuitas|MEDS - Rasio utang jangka dawa marang ekuitas|Orgenesis Corporation (ORGS) - Rasio silihan jangka dawa marang modal|RCM - Utang jangka dawa marang modal|Koefisien utang jangka dawa marang modal sharecare.com|Utang jangka dawa marang modal STRM (Streamline Health)|Rasio utang jangka dawa marang ekuitas Syra Health Corp (SYRA)|Utang jangka dawa marang modal AMEH (Apollo Medical Holdings, Inc.)|Model N Corporation - Utang jangka dawa marang modal|Utang jangka dawa marang ekuitas NextGen Healthcare (NXGN)